A new drug developed by Australian scientists is being heralded as a major breakthrough for people suffering from diabetic retinopathy, the main cause of blindness from diabetes.
The debilitating disease occurs in diabetic patients when tiny blood vessels in the retina of the eye, responsible for detecting light, leak fluid or hemorrhage.
However, the only treatment options available include laser surgery or eye injections known as anti-vascular endothelial growth factor therapy, which do not always prove to be effective.
Researcher Dr. Ka Ka Ting from the Centenary Institute in Sydney said health experts believe the new drug could potentially be used as a stand-alone therapy to treat those patients who fail to respond to the anti-VEGF treatment.
She said it also may work in conjunction with existing anti-VEGF treatments to extend the effectiveness of the treatment.
The team is now planning to conduct a full-scale clinical trial.
Source: Radio Pakistan